📊 AWHL Key Takeaways
Investment Thesis
Aspira Women's Health is in severe financial distress with negative stockholders' equity of -4.3M, indicating liabilities exceed assets. The company is burning cash at an alarming rate (-5.1M FCF) while revenue has collapsed 56.4% YoY, generating only 311K in the latest period, making near-term viability questionable.
AWHL Strengths
- Maintains positive current ratio of 1.39x suggesting short-term liquidity remains adequate
- Still holds 3.8M in cash providing runway for operations
- Gross profit positive at 4.5M indicating underlying product economics are present
AWHL Risks
- Negative stockholders' equity of -4.3M represents technical insolvency with liabilities exceeding assets
- Severe revenue decline of 56.4% YoY with only 311K revenue in latest period indicates collapsing business
- Operating cash burn of -5.0M combined with minimal revenue suggests company will exhaust cash within 9-12 months without turnaround
- Operating losses of -6.6M and net losses of -9.4M demonstrate inability to achieve profitability at current scale
- No insider buying activity in 90 days suggests management lacks confidence
Key Metrics to Watch
- Monthly revenue trend and stabilization timeline
- Operating cash burn rate and runway remaining with current cash balance
- Path to profitability or evidence of business stabilization
- Changes in stockholders' equity and debt restructuring plans
AWHL Financial Metrics
💡 AI Analyst Insight
Aspira Women's Health Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
AWHL Profitability Ratios
AWHL vs Default Sector
How Aspira Women's Health Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
AWHL Balance Sheet & Liquidity
AWHL 5-Year Financial Trend
5-Year Trend Summary: Aspira Women's Health Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-1.81 indicates the company is currently unprofitable.
AWHL Growth Metrics (YoY)
AWHL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.3M | -$1.9M | $-0.13 |
| Q2 2025 | $2.4M | -$1.9M | $-0.07 |
| Q1 2025 | $2.2M | -$1.9M | $-0.09 |
| Q3 2024 | $2.2M | -$2.3M | $-0.23 |
| Q2 2024 | $2.4M | -$2.3M | $-0.28 |
| Q1 2024 | $2.2M | -$4.6M | $-0.39 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AWHL Capital Allocation
AWHL SEC Filings
Access official SEC EDGAR filings for Aspira Women's Health Inc. (CIK: 0000926617)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AWHL
What is the AI rating for AWHL?
Aspira Women's Health Inc. (AWHL) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are AWHL's key strengths?
Maintains positive current ratio of 1.39x suggesting short-term liquidity remains adequate. Still holds 3.8M in cash providing runway for operations.
What are the risks of investing in AWHL?
Negative stockholders' equity of -4.3M represents technical insolvency with liabilities exceeding assets. Severe revenue decline of 56.4% YoY with only 311K revenue in latest period indicates collapsing business.
What is AWHL's revenue and growth?
Aspira Women's Health Inc. reported revenue of $311.0K.
Does AWHL pay dividends?
Aspira Women's Health Inc. does not currently pay dividends.
Where can I find AWHL SEC filings?
Official SEC filings for Aspira Women's Health Inc. (CIK: 0000926617) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AWHL's EPS?
Aspira Women's Health Inc. has a diluted EPS of $-0.30.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.